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ITK-SH3-mediated interactions, both with exogenous ligands and via intermolecular self-association with ITK-SH2, have been
shown to be important for regulation of ITK activity. The biological significance of these competing SH3 interactions is not
completely understood. Amutant of ITKwhere substitution of the SH3 domain with that of the related kinase BTK (ITK-BTK(SH3))
was used to disrupt intermolecular self-association of ITK while maintaining canonical binding to exogenous ligands such as SLP-
76. ITK-BTK(SH3) displays reduced association with SLP-76 leading to ineﬃcient transphosphorylation, reduced phosphorylation
of PLCγ1, and diminished Th2 cytokine production. In contrast, ITK-BTK(SH3) displays no defect in its localization to the T-cell-
APC contact site. Another mutation, Y511F, in the activation loop of ITK, impairs ITK activation. T cells expressing ITK-Y511F
display defective phosphorylation of ITK and its downstream target PLCγ1, as well as significant inhibition of Th2 cytokines. In
contrast, the inducible localization of ITK-Y511F to the T cell-APC contact site and its association with SLP-76 are not aﬀected.
The presented data lend further support to the hypothesis that precise interactions between ITK and its signaling partners are
required to support ITK signaling downstream of the TCR.
1. Introduction
Protein tyrosine kinases play a critical role in signal-
ing through the T-cell Antigen Receptor/CD3 (TCR-CD3)
molecular complex [1]. The Tec family of tyrosine kinases
regulates lymphocyte development, diﬀerentiation, and acti-
vation [2]. Among them, the Inducible T-Cell Kinase (ITK)
plays an important role in T-cell signaling and function [3].
ITK is the major Tec kinase expressed in T cells, regulating
intracellular Ca++ mobilization by phosphorylation and
activation of Phospholipase Cγ1 [4], TCR-induced actin
polymerization [5], and production of Th2 cytokines [6].
Even though ITK does not appear to be important for the
development of Th2 cells per se, it is critical for the expres-
sion of Th2 cell eﬀector function, as evidenced by defective
expression of Th2 cytokines in ITK-deficient animals [7].
ITK is structurally organized into domains that carry
out its catalytic function, domains that regulate its catalytic
activity, and domains that provide sites for interactions
with other signaling partners [8]. Even though the crystal
structure of full-length ITK has not been resolved, important
insights into its structure have been provided by NMR-based
analysis of individual ITK domains [2]. Previous in vitro
observations provide some hints toward a more complete
understanding of the mechanistic role of specific domains
within ITK [8]. There remains a need, however, for further
advances in our understanding of the role of specific ITK
domains in live cells.
The ITK SH3 domain has been shown to mediate more
than one protein-protein interaction through its conserved
binding site. Namely, ITK SH3 binds to the proline-rich
region of SLP-76 as well as to the SH2 domain of another
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ITK molecule [9–12]. The latter interaction does not involve
a canonical proline-rich site on the ITK SH2 domain but
nevertheless is mediated by the conserved SH3 binding
groove [12]. Thus, the ITK SH3 binding groove participates
in mutually exclusive interactions. An ITK variant where
the ITK-SH3 domain has been replaced with the SH3
domain of the related kinase BTK (henceforth designated
ITK-BTK(SH3)) was designed to block the intermolecular
interaction between ITK SH3 and SH2 domains while retain-
ing binding to a proline-rich ligand [13]. Previously, a group
of us (LM, AHA) had independently studied the properties
and biological eﬀects of this ITK variant using primarily
a heterologous nonlymphoid cellular system [13]. In the
present investigation, we have revisited this issue by using a
more relevant lymphoid system. We find that transfection of
this mutant construct into Jurkat T cells and ITK-deficient
mouse lymphoid cells displays significant eﬀects on the
transphosphorylation of ITK on tyrosine 511, the subsequent
phosphorylation of the downstream target PLCγ1, and on
the production of TCR-induced Th2 cytokines. The loss
of phosphorylation on Y511 and subsequent downstream
events mimic the signaling defects observed using direct
mutation of Y511 (ITK-Y511F). In contrast, neither variant
aﬀects the inducible localization of ITK to the T cell-APC
contact site, and diﬀerential eﬀects on the ability of ITK to
associate with its intracellular signaling partner SLP-76 are
observed.
2. Materials and Methods
2.1. Cells and Reagents. The Jurkat subline, JTag, was a kind
gift from Dr. Amnon Altman (La Jolla Institute of Allergy
and Immunology, La Jolla, CA). Raji cells (CCL-86) were
obtained from the American Type Culture Collection. Cells
were cultured in RPMI 1640 (Mediatech) supplemented
with 10% FBS, 2mM L-Glutamine, 100U/mL penicillin,
100 μg/mL streptomycin, 20mM HEPES (all obtained from
Mediatech) in a 37◦C humidified incubator in 5% CO2
atmosphere. Thymocytes were isolated from ITK-deficient
(Itk−/−) mice that were obtained from Dr. D. Littman (New
York University School of Medicine) and bred in our own
animal facility. Mice were male or female and used at 6–12
weeks of age. All experimental protocols using animals were
approved by the IACUC of San Diego State University.
2.2. Antibodies. Anti-human CD3ε monoclonal antibody
OKT3 was prepared in house from a hybridoma (CRL8001)
obtained from ATCC. Anti-mouse CD3ε (2C11; cat number
553058) and anti-mouse CD28 (37.51; cat number 553295)
were obtained from BD Pharmingen. Rabbit polyclonal
anti-ITK antibody (cat number 06-546; Upstate) was used
for immunoprecipitation and mouse monoclonal anti-ITK
antibody (clone 2F12; Upstate) was used for immunoblot-
ting. Antiphosphotyrosine (clone 4G10) antibody was from
Upstate and rabbit anti-SLP-76 IgG (cat number 4958)
was from Cell Signaling Technology. Anti-GFP (mixture of
clones 7.1 and 13.1) antibody was obtained from Roche.
For phosphoflow cytometry, we used Alexa 647-conjugated
antibodies to ITK pY511 (clone 24a/BTK), PLCγ1 pY783
(clone 27/PLC), and ZAP-70 pY319 all obtained from BD
Biosciences. Additional antibodies used in these studies were
DyLight 405-conjugated anti-Golden Syrian and Armenian
Hamster antibody (cat number 620-146-440; Rockland
Immunochemicals) and Goat anti-Armenian Hamster (cat
number 127-005-160; Jackson ImmunoResearch).
2.3. DNA Constructs. For the data displayed in Figures 1(a),
4, and 5, where the JTag T-cell line was utilized, Fluorescent
Protein (FP) chimeric cDNA constructs of ITK-WT, ITK-
Y511F, and ITK-BTK(SH3) were expressed into the pME18s
vector and transfected as previously described [14]. For
the data displayed in Figures 1(b), 1(c), 2, and 3, where
primary mouse thymocytes were utilized, GFP-chimeric ITK
genes were expressed in a pCMV-driven vector (Clontech).
The ITK-BTK(SH3) variant has been previously described
[13]. The ITK-Y511F point mutant, created by using the
GeneTailor site-directed mutagenesis kit (Invitrogen), was
originally described by Heyeck et al. [15]. pYC, a FP-cDNA
that contains no ITK, was used as negative control. It was
kindly provided to us by Dr. Tomaz Zal (MD Anderson) and
it has been previously described [16].
2.4. Treatment with Staphylococcal Enterotoxin E (SEE)
and Conjugate Formation. Raji cells, labeled with Cy5-ester
(Amersham), were preincubated with 10 μg/mL SEE (Toxin
Technology) for 2 hours at 37◦C. Following washing, they
were mixed with equal numbers (1 × 106) of JTag cells that
had been transfected with various ITK-expression vectors.
Cells were mixed, pelleted, and incubated in a total volume
of 200 μL for 3 minutes at 37◦C. They were then immediately
fixed with an equal volume of 4% paraformaldehyde (10
minutes on ice), washed, resuspended in 40 μL PBS,mounted
on slides, and analyzed by epifluorescence microscopy (Axio-
Vision Imaging System, Carl Zeiss) with 0.5 Neutral Density
filter. Morphological conjugates were selected by DIC using
stable conjugate criteria as previously described [17]. The
Localization Index was calculated as previously described
[11] using the NIH ImageJ software. Briefly, a transect across
the T cell was drawn, as shown in Figure 4(a), and the ratio
of pixel intensity (FP-ITK) at the contact site was divided by
that of the opposite noncontact site.
2.5. Transfection, Cell Stimulation, Immunoprecipitation, and
Immunoblotting. These procedures were performed as pre-
viously described [11]. For coimmunoprecipitation experi-
ments, Jukat cells, 20 × 106 per mL, were stimulated with
5 μg/mL of anti-CD3ε antibody OKT3 that was cross-
linked with an equal amount of rabbit anti-mouse IgG
and incubated for 1 minute at 37◦C. Cells were then lysed
and FP-ITK was immunoprecipitated with anti-GFP IgG
(per supplier’s recommendation), immune complexes were
resolved in 7.5% SDS-PAGE, and SLP-76 and ITK were
immunoblotted on PVDF membranes (Pall Life Sciences)
with the respective specific antibodies at 1 μg/mL. Signals
were detected by HRP-conjugated goat anti-mouse IgG
(Jackson Immunoresearch) using the SuperSignal West Pico
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Figure 1: Eﬀects of ITK-Y511F and ITK-BTK(SH3) mutations on ITK phosphorylation. (a) Jurkat cells that had been transfected
with the indicated ITK constructs were stimulated (+) or not (−) with anti-CD3ε antibodies and then lysed. ITK in the lysates
was immuno-precipitated (IP) with anti-ITK antibodies, immune complexes resolved by SDS-PAGE, proteins transferred onto PVDF
membranes and immuno-blotted (IB) sequentially with antiphosphotyrosine antibodies and anti-ITK antibodies as indicated. Bands were
visualized by chemiluminescence as described in Section 2. Numbers under the panels represent the fold increase in band signal intensity
(phosphorylation) compared to the respective nonstimulated control calculated as described in Section 2. Results are those from one of three
replicate experiments with similar results. (b) Murine thymocytes from ITK-deficient mice, nucleofected with the indicated ITK constructs,
were stimulated with anti-CD3ε antibodies for 1 minute and then analyzed for ITK phosphorylation by flow cytometry using Alexa 647-
tagged antibodies that react with ITK pY511, as described in Section 2. Results are displayed as cell number (linear scale) versus fluorescence
intensity (logarithmic scale). In each panel the open histograms represent nucleofected/nonstimulated cells, the black filled histograms
nonnucleofected/stimulated cells, and the grey filled histograms nucleofected/stimulated cells. The cDNA’s used in each nucleofection is
indicated to the right of each panel. The vertical line denotes the electronic gate used to calculate percent positive cells. The results are
those of one representative experiment. (c) Average (±SEM) percentage of pY511 positive cells of three replicate experiments (including the
experiment depicted in panel (b) performed as described in panel (b). The ∗ denotes that the average of pY511 positive cells in WT-ITK
nucleofected group is significantly diﬀerent from the rest of the groups at P < 0.05 (student’s t test). The dotted line demarcates the specific
anti-pY511 reactivity.
Chemiluminescence Substrate (Pierce) per manufacturer’s
directions. The ITK-SLP-76 Association Index was cal-
culated by densitometric analysis using the NIH ImageJ
software. Briefly, pixel intensity of each lane was divided
by the pixel intensity of its respective loading control lane,
then each obtained ratio was divided by the ratio of the
respective nonstimulated lane. Phosphorylation analysis was
performed similar to above. ITK was immunoprecipitated
by anti-ITK IgG (10 μg/mL) and phospho-ITK was immun-
oblotted by antiphosphotyrosine (4G10) IgG (2 μg/mL) and
detected by chemiluminescence as above. The fold change
in phosphorylation of each ITK mutant upon stimulation
conditions was calculated as described above for the coim-
munoprecipitation experiments.
2.6. Nucleofection. Thymocytes were isolated from the thymi
of ITK-deficient mice by separation through a nylon mesh.
Cells, 10 × 106, were nucleofected with 15 μg DNA of the
various ITK-constructs in 100 μL volume using the reagents
provided by the manufacturer (Lonza) and the Amaxa
Nucleofector II (program X-001) following the manufactur-
er’s instructions. The nucleofected cells were then cultured in
1.5mL of Lonza Nucleofector medium supplemented with
10% FBS at 37◦C in a humidified 5% CO2 atmosphere for
24 hours following the manufacturer’s instructions, before
used in experiments. An aliquot of the cells were mock
nucleofected by treating them identically to the above, but
in the absence of DNA.
2.7. Cell Stimulation and Phosphoflow Cytometry. Thymo-
cytes were stimulated and analyzed for intracytoplasmic
phosphorylation using a modification of a previously pub-
lished method [18, 19]. Following nucleofection with GFP-
ITK cDNA constructs thymocytes were resuspended in
500 μL of ice-cold medium containing Armenian Hamster
anti-mouse CD3ε (1 μg/mL) antibody and incubated for 1
hour on ice. Cells were then pelleted and resuspended in
500 μL of ice-cold medium containing a premixed cocktail
of 7 μg goat anti-Armenian Hamster antibody and 0.5 μg of
DyLight 405-conjugated anti-Golden Syrian and Armenian
Hamster antibodies and incubated for an additional 30
minutes on ice. The samples were then stimulated by placing
them in a 37◦C water bath for 1 minute and immediately
fixed by adding an equal volume of ice-cold paraformalde-
hyde (4%). Following fixation, cells were resuspended in
1mL of ice cold 95% methanol and incubated overnight
at 4◦C. After several washes with PBS-0.5% BSA, samples
were blocked by incubation with 100 μg/mL of mouse IgG
(1 hour RT◦) and stained with the respective Alexa 647-
conjugated anti-phospho-specific antibodies (1 hour, room
temperature, in the dark) following the manufacturer’s
recommendation. Following several washes, the cells were
4 Journal of Signal Transduction
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Figure 2: Reduced transphosphorylation of PLCγ1 by ITK-Y511F and ITK-BTK(SH3) mutants. (a) murine thymocytes from ITK-
deficient mice, nucleofected with the indicated ITK constructs, were stimulated with anti-mouse-CD3ε antibodies and then analyzed
for PLCγ1 phosphorylation using Alexa 647-tagged antibodies that react with PLCγ1 pY783, as described in Section 2. Results are
displayed as cell number (linear scale) versus fluorescence intensity (logarithmic scale). In each panel, the open histograms
represent nucleofected/nonstimulated cells, the black filled histograms nonnucleofected/stimulated cells, and the grey filled histograms
nucleofected/stimulated cells. The cDNA’s used in each nucleofection is indicated to the right of each panel. The vertical line denotes
the electronic gate used to calculate percent positive cells. The results are those of one representative experiment using the same cells as
in Figure 1(b). (b) Average (±SEM) percentage of pY783 positive cells of three replicate experiments (including experiment in panel (a)
performed as described in panel (a). The cells used in these experiments are the same as those used in Figure 1(c). The ∗ denotes that the
average of pY783 positive cells in WT-ITK nucleofected group is significantly diﬀerent from the rest of the groups at P < 0.05 (Student’s t
test). The dotted line demarcates the specific anti-pY783 reactivity. (c) Average (±SEM) percentage of pY319 positive cells of four replicate
experiments performed as described in panel (a), but analyzed for ZAP-70 phosphorylation using Alexa 647-tagged antibodies that react
with ZAP-70 pY319.
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Figure 3: Deficient Th2 cytokine production by ITK-Y511F and ITK-BTK(SH3) mutants. Murine thymocytes were nucleofected with the
indicated ITK constructs and then cultured under Th2 skewing conditions as described in Section 2. Culture supernatants were assayed in
duplicate for IL-4 (a) and IL-13 (b) using commercial ELISA assay kits and followingmanufacturer’s recommendations. Results are displayed
as the averages (±SEM) of three replicate experiments for IL-4 and two replicate experiments for IL-13. Negative controls (nonstimulated
cell-culture supernatants) contained 69 pg/mL IL-4 and undetectable (<4 pg/mL) IL-13.
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Figure 4: Inducible localization of ITK-Y511F and ITK-BTK(SH3) to the T-cell-APC contact site. Jurkat cells transfected with fluorescent
protein chimeric constructs of WT-ITK, ITK-Y511F, or ITK-BTK(SH3) or with a construct containing fluorescent protein without ITK
(pYC), as a transfection control, were incubated with Raji cells that had been pretreated (+SEE) or not treated (−SEE) with SEE for 3
minutes at 37◦C. Cells were then fixed in paraformaldehyde and analyzed using epifluorescence microscopy. (a) Representative experiment
displaying localization of ITK as YFP fluorescence intensity (right hand panels) in the presence (top panels) or absence (bottom panels)
of SEE. Diﬀerential interference contrast images are displayed in the left hand panels for ease of orientation. (b) Results of three replicate
experiments, performed, and analyzed as in (a), are displayed as the average Localization Index (±SEM) for each ITK construct calculated
as described in Section 2. WT/NS denotes nonstimulated cells transfected with WT-ITK, as negative control. The number of conjugates
analyzed in each group are WT, N = 52; Y511F, N = 37; BTK(SH3), N = 32; pYC, N = 10, WT/NS; N = 10.
analyzed using a FACSAria flow cytometer (BD Biosciences)
and FlowJo 7 (FlowJo) software. In parallel cultures, control
nonstimulated thymocytes were treated as above, but in
the absence of anti-CD3ε. In order to analyze phosphoflow
signals in stimulated cells, we first established an electronic
gate encompassing GFP-positive (transfected) cells using
mock-transfected cells as controls. Cells included in that gate
were further gated for the top 15%MFI of DyLight 405 signal
(anti-CD3ε positive; defined as stimulated cells). Cells within
this gate were analyzed for specific relevant Alexa 647 signal
(phosphotyrosine-positive cells) and plotted as cell number
versus Alexa 647 fluorescence intensity.
2.8. Skewing, Cytokine Production, and Measurement. In or-
der to increase the frequency towards Th2 cytokine pro-
duction, thymocytes nucleofected as described above were
skewed using modifications of previously published proto-
cols [7, 20, 21]. Briefly, thymocytes were collected 4 hrs after
nucleofection and resuspended at 2 × 106 cells per mL in
Lonza Medium-10% FBS containing anti-CD28 (1 μg/mL)
and anti-IL12 (20 μg/mL) antibodies. Cells were placed into
96-well U-bottom well plates (2×105 per well) that had been
precoated with anti-CD3ε antibody 2C11 (1 μg/mL) and
incubated overnight at 37◦C in a humidified incubator with
5% CO2 atmosphere. Cells were then supplemented with IL2
(5 ng/mL) and IL4 (10 ng/mL) and incubated for an addi-
tional 2 days. Cells were then resuspended in fresh medium
containing anti-CD28 (1 μg/mL) antibody and transferred to
new anti-CD3ε coated plate wells and incubated for 24 hours
as above. Cell-free culture supernatants were assayed for IL-
4 and IL-13 using commercially obtained ELISA kits. The
limit of detection in the IL-4 kit (BD Bioscience, cat number
555232) is 8 pg/mL and for the IL-13 kit (eBioscience, cat
number 88-7137-88) is 4 pg/mL. Analysis was performed
in duplicate wells of 96-well ELISA plates (BD Bioscience)
following the manufacturer’s recommendations and read on
eMax Precision Microplate Reader using SoftMax Pro v5.0
software (Molecular Devices).
3. Results
3.1. Eﬀect of ITK-BTK(SH3) Mutation on ITK Phosphorylation.
Activation of ITK depends on transphosphorylation of
tyrosine 511 in the activation loop of the kinase [15, 22].
Using Jurkat T cells transfected with either wild-type ITK, a
Y511F-ITK mutant, or ITK-BTK(SH3), we first assessed ITK
phosphorylation levels following stimulation through the
TCR (Figure 1(a)). As expected, mutation of tyrosine 511
to phenylalanine precluded TCR-mediated phosphorylation
of ITK in Jurkat T cells; TCR-induced phosphorylation
6 Journal of Signal Transduction
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Figure 5: Association of ITK-Y511F and ITK-BTK(SH3) with SLP-76. (a) Jurkat cells that had been transfected with the indicated GFP-ITK
constructs were stimulated (+) or not (−) with anti-CD3ε antibodies and then lysed. ITK in the lysates was immunoprecipitated (IP) with
anti-GFP antibodies, immune complexes resolved by SDS-PAGE, proteins transferred onto PVDF membranes, and immunoblotted (IB)
sequentially with anti SLP-76 (top panel) and anti-ITK (bottom panel) antibodies. Bands were visualized by chemiluminescence as described
in Section 2. Numbers under each blot represent the association index between each ITK-variant and SLP-76 calculated as described in
Section 2. Results are those from one of three replicate experiments. (b) average (±SEM) ITK-SLP-76 association index of three replicate
experiments (including the experiment depicted in panel (a) performed as described in panel (a). Numbers in brackets denote P values
calculated by the Student’s t test.
signal of ITK-Y511F transfectants was similar to that of
nonstimulated controls (Figure 1(a), top panel). In contrast,
ITK-BTK(SH3) was phosphorylated, albeit at lower levels
than wild type ITK (Figure 1(a), top panel). In the displayed
experiment there was a reduction of about 15% in signal
intensity.
Since Jurkat cells express endogenous ITK that may
aﬀect the outcome, we wished to confirm the above results
more quantitatively in a cellular system devoid of ITK. To
this end, we nucleofected thymocytes obtained from ITK-
deficient mice with the three ITK constructs (wild type,
Y511Y, and ITK-BTK(SH3)) and quantified TCR-mediated
phosphorylation of ITK by phospho-flow cytometry using
an antibody that reacts with ITK-phosphotyrosine 511. Since
an antibody made specifically against ITK-pY511 is not
available, we used an antibody that was generated against the
analogous amino acid (pY551) of the related kinase BTK and
cross-reacts with ITK pY511 [23]. We observed that mock-
or nonnucleofected, TCR-stimulated thymocytes from ITK-
deficient mice displayed significant reactivity (30%) upon
staining with this antibody (Figure 1(b), dotted line open
histogram and Figure 1(c)). Thus, it appears that this
antibody has reactivity to other phosphotyrosine residues,
most likely those of other Tec kinases present in the cells (i.e.,
TEC and RLK). Importantly, however, upon nucleofection
with WT-ITK there was a fifty percent increase in the
phosphosignal (Figure 1(b), grey histogram in top panel and
Figure 1(c)) that was significant at P < 0.05 (Figure 1(c),
comparison between Mock and WT groups). In contrast,
no significant increase from Mock- or nonnucleofected cells
occurred in thymocytes nucleofected with either ITK-Y511F
or ITK- BTK(SH3) (Figures 1(b) and 1(c)). It should be noted
that the analyzed cells in all groups displayed equivalent
expression of the nucleofected genes as assessed by the
fluorescence intensities (MFI signal) of the GFP-nucleofected
constructs. In the representative experiment shown in
Figure 1(b) the MFI values for the nucleofected cDNA’s
were WT:1940, Y511F:1920, and BTK(SH3):1984. Similarly
equivalent were the MFI’s for the three replicate experiments
shown in Figure 1(c). Thus, while ITK-BTK(SH3) appears
to be phosphorylated in transfected Jurkat cells, albeit at
lower levels compared to WT-ITK, this variant fails to be
phosphorylated on Y511 when nucleofected into thymocytes
derived from ITK-deficient mice. One interpretation of this
observation could be that the phosphorylation of ITK-
BTK(SH3) we see in the Jurkat cell system (Figure 1(a)) might
be due to the possible interaction between the endogenous
ITK-SH3 domain with the SH2 domain of the transfected
ITK-BTK(SH3).
3.2. Reduced Transphosphorylation of PLCγ1 by ITK-Y511F
and ITK-BTK(SH3) Mutants. Previous studies have shown
that upon TCR engagement, ITK phosphorylates PLCγ1
Journal of Signal Transduction 7
on tyrosine 783 [4]. This is a critical phosphorylation
target for the activation of PLCγ1 and downstream sig-
naling events [4]. To determine the ability of ITK-Y511F
and ITK-BTK(SH3) to phosphorylate PLCγ1 on Tyr 783,
we nucleofected thymocytes from ITK-deficient mice with
the two mutant constructs and compared the inducible
phosphorylation of PLCγ1-Y783 by phosphoflow cytome-
try using a specific anti-pY783 antibody. It is interesting
that TCR-stimulated mock- or nonnucleofected thymocytes
displayed significant pY783 phosphorylation (Figures 2(a)
and 2(b)). Since the cells lack ITK and the specificity of
the anti-pY783 reactivity has been previously documented
[24], we interpret this finding as indicating that other
kinases are able to phosphorylate PLCγ1 at this critical
residue. Importantly, however, upon nucleofection withWT-
ITK, the phosphosignal nearly doubles indicating increased
phosphorylation of PLCγ1 Y783 specifically by wild-type
ITK (Figures 2(a) and 2(b)). Compared to mock- or
nonnucleofected cells, this increase is significant at P <
0.05. In contrast, nucleofection with either ITK-Y511F or
ITK-BTK(SH3) did not significantly increase phosphorylation
above the mock-transfected controls. The specificity of the
PLCγ1 Y783 phosphorylation event is further demonstrated
by the fact that none of these transfectants had any eﬀect
on the phosphorylation of the upstream signaling molecule
ZAP-70 (Figure 2(c)). The cells used for the of PLCγ1
phosphorylation analysis were aliquots from the same cells
used in the experiments of Figures 1(b) and 1(c). As such,
they displayed equivalent expression of the nucleofected
genes as described above.
3.3. Deficient Th2 Cytokine Production by ITK-Y511F and
ITK-BTK(SH3) Mutants. During the course of analyzing
ITK and PLCγ1 phosphorylation in thymocytes from ITK-
deficient mice, we also examined Th2 cytokine production
in the context of wild-type and variant ITKs. ITK is critical
for the transcriptional activation of the physically clustered
Th2 cytokine genes IL-4 and IL-13 [25]. Therefore, we
wanted to determine whether the transphosphorylation-
deficient (ITK-Y511F) and the ITK-BTK(SH3) variant could
aﬀect the production of these two cytokines upon TCR-
stimulation. To accomplish this, we skewed the nucleofected
thymocytes towards Th2 cytokine production in order to
increase the relative frequency of the cells producing these
cytokines. Compared to WT-ITK nucleofected thymocytes,
those nucleofected with either of the two mutant genes (ITK
Y511F or ITK-BTK(SH3)) produced background cytokine
levels similar to those seen with mock-transfected controls
(Figures 3(a) and 3(b)).
3.4. Inducible Localization of ITK-BTK(SH3) and ITK-Y511F
to the T-Cell-APC Contact Site. All of the results described
above (Figures 2 and 3) for the ITK Y511F mutant and the
ITK-BTK(SH3) variant are consistent with the observed lack
of phosphorylation on Y511 within ITK (Figure 1). It was
expected that the ITK Y511F mutant would lack phosphory-
lation on Y511 but the finding that the ITK-BTK(SH3) variant
is also poorly phosphorylated on Y511 when nucleofected
into thymocytes derived from ITK-deficient mice was not
anticipated. To better understand why the ITK-BTK(SH3)
variant is not eﬃciently phosphorylated on Y511, we next
examined localization of wild-type and mutant ITKs to the
T cell-APC contact site and more specifically association
of these ITK mutants with SLP-76. It has been previously
demonstrated that upon T cell activation, ITK colocalizes
with the TCR-CD3 complex at the APC-T cell contact site
[14, 26]. Whether ITK requires transphosphorylation on its
Tyr 511 before its translocation to the contact site has not
been previously addressed. Moreover, we wished to ascertain
whether the poor phosphorylation on Y511 in the ITK-
BTK(SH3) variant might be due to improper localization. The
data in Figure 4 clearly demonstrate that both ITK Y511F
and ITK-BTK(SH3) localize in a manner that is similar to
wild-type ITK in Jurkat cells. For the ITK Y511F mutant
in particular, it can be concluded that phosphorylation at
this site is not a prerequisite for inducible localization to
the T cell-APC contact site. The data also indicate that the
ITK-BTK(SH3) variant performs as well as wild-type ITK; the
diminished self-association of the ITK-BTK(SH3) variant, as
well as the observed decrease in phosphorylation of Y511
(Figure 1), do not aﬀect its ability to inducibly localize to
the APC-T-cell contact site (Figure 4). Upon stimulation,
WT-ITK displayed approximately two-fold increase in its
localization index that was similar to that seen in both Y511F
and ITK-BTK(SH3) transfectants (Figure 4(b)). Control, non-
stimulated cells transfected withWT-ITK or with a construct
containing fluorescent protein without ITK (pYC) displayed
insignificant localization (Figure 4(b)).
3.5. Association of ITK-Y511F and ITK-BTK(SH3) with SLP-76.
We next specifically examined the SH3-mediated interaction
of ITK following TCR stimulation since the ITK-BTK(SH3)
variant carries a nonnative SH3 domain. It has been previ-
ously demonstrated that TCR-induced activation results in
ITK association with the adaptor protein SLP-76 [10, 11].
To address whether ITK-BTK(SH3) maintains normal SLP-76
association, ITK (wild type, ITK-BTK(SH3), or ITK Y511F)
was immunoprecipitated from lysates of cells that had been
transfected with these mutants and stimulated through
the TCR. SLP-76 coimmunoprecipitation was assessed by
blotting with an anti-SLP-76 antibody (Figure 5). The results
demonstrate that the Y511F mutation does not significantly
aﬀect the inducible association of ITK with SLP-76 (Figures
5(a) and 5(b)). However, the association of the ITK-BTK(SH3)
variant with SLP-76 is significantly reduced (∼32% Figures
5(a) and 5(b).
4. Discussion
Previous NMR-based analysis uncovered a novel intermolec-
ular association between the SH2 and SH3 domains of
ITK that does not involve conventional proline-rich motifs
[12]. Instead, this association involves the interaction of the
ITK SH3 binding pocket with four loops of the ITK SH2
domain located at a site distinct from the phosphotyrosine
binding site of this domain [12]. The SH2/SH3 ITK domain
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interaction appears to be specific, as these domains do not
interact with the respective domains of non-Tec kinases,
thus suggesting a functionally important role [12].Moreover,
the ITK SH2 domain does not interact with BTK SH3, the
domain most closely related to ITK SH3. These observations
inspired the construction of a variant of ITK where the
SH3 domain was replaced with that of BTK [13]. Even
though this ITK variant (ITK-BTK(SH3)) retained the ability
to bind a canonical proline-rich peptide ligand, it displayed
limited ability to interact with the ITK SH2 domain in
an intermolecular fashion, thus becoming a useful reagent
for studying the functional role of intermolecular ITK self-
association [13].
In the past, a group of us (LM, AHA), through a
series of in vitro assays, independently found that the ITK-
BTK(SH3) variant displays reduced self-association compared
to the wild-type ITK molecule, maintains normal binding
to a proline-rich peptide ligand derived from SLP-76, and
displays normal phosphorylation of Tyr 511 in its activation
loop that is critical for the enzymatic activation of ITK [15,
22]. Furthermore, at higher concentration, ITK-BTK(SH3)
was found to exhibit increased catalytic activity towards
its target PLCγ1 compared to wild-type ITK at the same
concentration, led to increased ERK phosphorylation, and
increased calcium flux compared to wild-type ITK [13].
Since these previous studies were performed in vitro using
a primarily heterologous nonlymphoid system and retroviral
transduction, we determined that further analysis of the ITK-
BTK(SH3) variant was warranted. Therefore, in the present
investigation, we have revisited this issue using a more
relevant lymphoid cellular system.
When human Jurkat T cells were transfected with ITK-
BTK(SH3) and the inducible phosphorylation of Tyr 511 was
assessed, we found a diﬀerent result than the one described
above. Namely, a decrease in transphosphorylation of Tyr
511 (Figure 1(a)). To confirm this in a more physiological
target, we nucleofected primary mouse lymphoid cells (thy-
mocytes) with ITK-BTK(SH3) and assessed inducible phos-
phorylation of Tyr 511 by phosphoflow cytometry. The data
again indicate that Tyr 511 phosphorylation of ITK-BTK(SH3)
was significantly lower than WT-ITK and almost as low as
that observed for the ITK Y511F mutant. The subsequent
observations that downstream PLCγ1 phosphorylation and
IL-4 and IL-13 production are significantly reduced are com-
pletely consistent with the defective phosphorylation of Tyr
511 since ITK is not activated and does not phosphorylate
PLCγ1 unless the ITK activation loop tyrosine (Y511) is
phosphorylated [15, 22].
In an eﬀort to understand why the ITK-BTK(SH3) variant
fails to get phosphorylated on Y511 in the nucleofected lym-
phoid system, we have focused on its assembly into the SLP-
76/LAT signaling complex. Multiple interactions mediated
by diﬀerent domains of ITK serve to colocalize ITK with
its signaling partners [9, 10, 27, 28]. Our data in Figures 4
and 5 suggest that while the ITK-BTK(SH3) variant inducibly
localizes to the T cell-APC contact site in a manner that
is indistinguishable from wild-type ITK, the specific SH3-
mediated interaction of ITK with SLP-76 is not maintained
in the ITK-BTK(SH3) variant.
Previous results indicate that a short model peptide
(residues 184–195 of SLP-76), representing the minimal
binding site of the SLP-76 polyproline-rich region to ITK-
SH3 domain [9], has nearly identical binding aﬃnity to
both ITK- and BTK-SH3 domains [13]. Based on these
data, we expected that ITK-BTK(SH3) would exhibit normal
binding to SLP-76. However, the data presented here do not
bear this out, ITK-BTK(SH3) does not associated with SLP-
76 to the same extent as wild-type ITK (Figure 5). Thus,
the short SLP-76 proline-rich peptide, while suﬃcient for
inhibition of the TCR-induced association between ITK and
SLP-76 both in vitro and in vivo [11], may not be a good
model for the association between full-length ITK-BTK(SH3)
and full-length SLP-76. It is possible that the interaction
between the SH3 domain of ITK and SLP-76 extends beyond
the canonical binding motif within SLP-76 and cannot
be accurately mimicked using a simple linear proline-rich
peptide ligand. Amino acid sequence diﬀerences between
the ITK- and BTK-SH3 domains might then manifest in
the reduced association of ITK-BTK(SH3) with SLP-76. Thus,
in view of the lack of complete homology between the
ITK- and BTK-SH3 domains, it is possible that additional
residues beyond the minimal amino acid sequence of the
short peptide may more accurately reflect the complete ITK
binding site that would show aﬃnity diﬀerences between ITK
and BTK SH3 domains in an in vitro binding assay.
In the context of the cellular system developed here,
we suggest that diminished binding between ITK and SLP-
76 is responsible for the reduced activation of ITK as
measured by phosphorylation on Y511. This is consistent
with previous work showing that specific disruption of the
ITK SH3/SLP-76 interaction with a cell permeable peptide
targeted to the ITK SH3 domain results in inhibition of
transphosphorylation of ITK on Y511 [11]. Loss of Y511
phosphorylation in turn explains the reduced phospho-
rylation of PLCγ1 and reduced cytokine production. The
question remains why the system developed by Min et al.
showed increased PLCγ1 activation (as measured by calcium
flux) and increased downstream signaling (as measured by
ERK phosphorylation).
A possible explanation for the disparate results between
the earlier work of Min et al. and the findings reported
here might lie in levels of protein expression in the diﬀerent
systems used to examine the behavior of the ITK-BTK(SH3)
variant. It is possible that the retroviral expression system
used by Min et al. produced levels of ITK protein in the
ITK−/− T cells that were suﬃcient to overcome the reduced
aﬃnity of the ITK-BTK(SH3) variant for SLP-76 that has now
become apparent in the current study. Increased protein lev-
els would drive the binding event toward SLP-76 associated
ITK-BTK(SH3) to the extent that Y511 phosphorylation levels
would not be adversely aﬀected and the enhanced activity
of the ITK-BTK(SH3) variant (presumably increased due to
loss of self-association) leads to increased signaling when
compared to transduction of the same levels of wild-type
ITK in the same system. In the current work, we were unable
to assess the eﬀect of altered self-association of the ITK-
BTK(SH3) variant since the required activation of ITK by
transphosphorylation of Y511 proved ineﬃcient.
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In addition to the regulation of ITK activation by
SH3/SH2 intermolecular interactions, ITK activation is also
regulated by intermolecular interactions mediated by its PH
domain. The PH domain of ITK is critical for TCR-induced
recruitment to and association with the cell membrane [14].
Previous studies have suggested that cytoplasmic monomeric
ITK becomes recruited to the cell membrane where it forms
dimers and/or higher order multimers through intermolec-
ular interactions regulated by the PH domain [26, 29].
Furthermore, data from Huang et al. have suggested that the
PH domain-mediated aggregation of ITK might be regulated
by membrane phospholipids [26]. The observation that the
PH domain is critical for ITK membrane recruitment [14],
whereas disruption of SH3-SH2 intermolecular interaction
does not aﬀect recruitment (Figure 4), suggests that the two
types of interaction may regulate ITK activation through
diﬀerent mechanisms. How the intermolecular associations
regulated by the PH domain influence the events leading to
ITK activation is currently under investigation.
Mutational analysis constitutes a powerful approach for
establishing structure-function relationships in biological
molecules. Very often a given mutation is designed to com-
pletely abolish a site of posttranslational modification. A
case in point is the ITK Y511F mutant studied here. The
biochemical eﬀects of Y511 mutagenesis have been previ-
ously reported [15, 22], yet the eﬀects of this mutation on
Th2 cytokines that are known to be regulated by ITK [7]
have not been specifically addressed before. As expected,
total disruption of ITK phosphorylation on tyrosine 511 by
mutation to phenylalanine aﬀects phosphorylation of the
downstream target, tyrosine 783 of PLCγ1, thus establishing
this phenomenon in a physiologically relevant context. In
view of the observed properties of this mutant, its eﬀect
on the Th2 signature cytokines IL-4 and IL-13 is not
surprising. A novel observation is that ITK-Y511F is fully
capable of localizing to the T cell-APC contact site and of
associating with the adaptor protein SLP-76. Thus, trans-
phosphorylation of ITK appears to be either a later event that
follows recruitment to the contact site and interaction with
SLP-76, and/or the phosphorylation status of Y511 in ITK
simply has no eﬀect on the interactions required to stabilize
ITK at the contact site and bound to SLP-76.
In contrast to the Y511F mutant, the ITK-BTK(SH3)
variant represents a significantly more complex mutational
approach. Unlike posttranslational modifications that can be
abrogated by a single amino acid change, protein-protein
interactions involve numerous residues and often multiple
protein interaction surfaces overlap on the surface of a single
protein. The ITK-BTK(SH3) variant was designed to abolish
one protein-protein interaction (that between ITK SH3
and SH2) while maintaining the canonical ligand binding
characteristic of the SH3 domain (binding to the proline-rich
site on SLP-76). Even though in vitro experiments supported
this approach [13], the present studies using nucleofection
of ITK-BTK(SH3) into primary lymphoid cells showed a
diﬀerent outcome; namely, the BTK SH3 domain substituted
into the ITK protein does not maintain canonical ligand
binding and thus results in diminished ITK signaling. Adding
to the complexity associated with targeting protein interfaces
by mutation, it is also important to note that intermolecular
binding events are influenced by the cellular concentrations
of the diﬀerent protein species. Thus, variations in protein
expression levels in diﬀerent experimental systems have the
potential to yield diﬀerent outcomes.
In conclusion, the data presented here and those previ-
ously published suggest that a number of diﬀerent mech-
anisms may regulate the activation of ITK. In addition, as
the details of intracellular signaling pathways are investigated
by probing complex protein interaction interfaces, it will
be important to consider how the experimental setup can
influence the results.
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